Sebastian Palmqvist
171 – 180 of 199
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
The Montreal Cognitive Assessment : Normative Data from a Large Swedish Population-Based Cohort
- Contribution to journal › Article
-
Mark
18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease
- Contribution to journal › Article
- 2016
-
Mark
Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis.
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography.
- Contribution to journal › Article
-
Mark
Reply : Do we still need positron emission tomography for early Alzheimer's disease diagnosis?
- Contribution to journal › Letter
-
Mark
Assessing risk for preclinical β-amyloid pathology with APOE, cognitive, and demographic information
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Plasma tau in Alzheimer disease
- Contribution to journal › Article
-
Mark
CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios : better diagnostic markers of Alzheimer disease
- Contribution to journal › Article
